• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三维类器官模型再现了晚期人视网膜母细胞瘤的肿瘤发生和药物反应特征。

A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma.

机构信息

Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Department of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Sci Rep. 2018 Oct 23;8(1):15664. doi: 10.1038/s41598-018-34037-y.

DOI:10.1038/s41598-018-34037-y
PMID:30353124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6199308/
Abstract

Persistent or recurrent retinoblastoma (RB) is associated with the presence of vitreous or/and subretinal seeds in advanced RB and represents a major cause of therapeutic failure. This necessitates the development of novel therapies and thus requires a model of advanced RB for testing candidate therapeutics. To this aim, we established and characterized a three-dimensional, self-organizing organoid model derived from chemotherapy-naïve tumors. The responses of organoids to drugs were determined and compared to relate organoid model to advanced RB, in terms of drug sensitivities. We found that organoids had histological features resembling retinal tumors and seeds and retained DNA copy-number alterations as well as gene and protein expression of the parental tissue. Cone signal circuitry (M/L cells) and glial tumor microenvironment (GFAP cells) were primarily present in organoids. Topotecan alone or the combined drug regimen of topotecan and melphalan effectively targeted proliferative tumor cones (RXRγ Ki67) in organoids after 24-h drug exposure, blocking mitotic entry. In contrast, methotrexate showed the least efficacy against tumor cells. The drug responses of organoids were consistent with those of tumor cells in advanced disease. Patient-derived organoids enable the creation of a faithful model to use in examining novel therapeutics for RB.

摘要

持续性或复发性视网膜母细胞瘤 (RB) 与晚期 RB 中玻璃体内或/和视网膜下种子的存在相关,是治疗失败的主要原因。这需要开发新的治疗方法,因此需要建立晚期 RB 的模型来测试候选治疗方法。为此,我们建立并鉴定了一种源自化疗初治肿瘤的三维自组织类器官模型。我们测定了类器官对药物的反应,并根据药物敏感性将类器官模型与晚期 RB 进行了比较。我们发现,类器官具有类似于视网膜肿瘤和种子的组织学特征,并保留了亲本组织的 DNA 拷贝数改变以及基因和蛋白表达。类器官中主要存在视锥信号通路(M/L 细胞)和神经胶质肿瘤微环境(GFAP 细胞)。单独使用拓扑替康或拓扑替康和氨甲蝶呤联合药物方案在药物暴露 24 小时后可有效靶向类器官中的增殖性肿瘤锥体细胞(RXRγ Ki67),阻止有丝分裂进入。相比之下,甲氨蝶呤对肿瘤细胞的疗效最差。类器官的药物反应与晚期疾病中肿瘤细胞的反应一致。患者来源的类器官使创建忠实的模型成为可能,可用于研究 RB 的新型治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/98bd8efafbb4/41598_2018_34037_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/261df0e92640/41598_2018_34037_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/8a5d54f1c422/41598_2018_34037_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/0a9c38c14f82/41598_2018_34037_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/842e7c1fe42f/41598_2018_34037_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/84f1cd6cf486/41598_2018_34037_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/98bd8efafbb4/41598_2018_34037_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/261df0e92640/41598_2018_34037_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/8a5d54f1c422/41598_2018_34037_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/0a9c38c14f82/41598_2018_34037_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/842e7c1fe42f/41598_2018_34037_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/84f1cd6cf486/41598_2018_34037_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/6199308/98bd8efafbb4/41598_2018_34037_Fig6_HTML.jpg

相似文献

1
A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma.三维类器官模型再现了晚期人视网膜母细胞瘤的肿瘤发生和药物反应特征。
Sci Rep. 2018 Oct 23;8(1):15664. doi: 10.1038/s41598-018-34037-y.
2
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids.患者来源的视网膜母细胞瘤类器官中具有最小毒性的舒尼替尼疗效。
J Exp Clin Cancer Res. 2023 Feb 1;42(1):39. doi: 10.1186/s13046-023-02608-1.
3
pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.pRB 耗竭的多能干细胞视网膜类器官重现视网膜母细胞瘤发生过程中的细胞状态转变,并提示 pRB 在视网膜细胞分化中的重要作用。
Stem Cells Transl Med. 2022 Apr 29;11(4):415-433. doi: 10.1093/stcltm/szac008.
4
INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.视网膜母细胞瘤活动性玻璃体种植的玻璃体内化疗:192次连续注射后的结果。2015年霍华德·纳quin讲座
Retina. 2016 Jun;36(6):1184-90. doi: 10.1097/IAE.0000000000000903.
5
Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration.三维视网膜母细胞瘤培养物作为玻璃体种子模型,用于化疗渗透的活细胞成像。
Int J Mol Sci. 2019 Mar 2;20(5):1077. doi: 10.3390/ijms20051077.
6
Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.玻璃体内化疗治疗视网膜母细胞瘤的疗效与毒性:四年经验
Ophthalmology. 2017 Apr;124(4):488-495. doi: 10.1016/j.ophtha.2016.12.015. Epub 2017 Jan 12.
7
Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.联合玻璃体内注射马法兰和拓扑替康治疗视网膜母细胞瘤难治性或复发性玻璃体内播散。
JAMA Ophthalmol. 2014 Aug;132(8):936-41. doi: 10.1001/jamaophthalmol.2014.414.
8
Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.既往接受化疗后,对大量持续性或复发性视网膜母细胞瘤视网膜下种植灶进行二期和三期动脉内化疗:30只眼的长期肿瘤控制和眼球挽救情况
J AAPOS. 2016 Aug;20(4):337-42. doi: 10.1016/j.jaapos.2016.05.009. Epub 2016 Jun 18.
9
Topotecan combination chemotherapy in two new rodent models of retinoblastoma.拓扑替康联合化疗在两种新的视网膜母细胞瘤啮齿动物模型中的应用
Clin Cancer Res. 2005 Oct 15;11(20):7569-78. doi: 10.1158/1078-0432.CCR-05-0849.
10
Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.眼内注射美法仑治疗持续性或复发性视网膜母细胞瘤玻璃体内播散:初步结果。
JAMA Ophthalmol. 2014 Mar;132(3):319-25. doi: 10.1001/jamaophthalmol.2013.7666.

引用本文的文献

1
The application of liver cancer organoids in tumour precision medicine: A comprehensive review.肝癌类器官在肿瘤精准医学中的应用:一项综述
ILIVER. 2025 Jul 5;4(3):100179. doi: 10.1016/j.iliver.2025.100179. eCollection 2025 Sep.
2
Optimized Urb. bulb extract on the inhibition of 3D retinoblastoma spheroids cultured in type I murine collagen.优化后的城市球根提取物对在I型鼠胶原中培养的3D视网膜母细胞瘤球体的抑制作用。
Int J Ophthalmol. 2025 May 18;18(5):802-812. doi: 10.18240/ijo.2025.05.05. eCollection 2025.
3
In vitro model of retinoblastoma derived tumor and stromal cells for tumor microenvironment (TME) studies.

本文引用的文献

1
Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.眼内化疗治疗视网膜母细胞瘤:眼内种子以外的扩展应用。
Br J Ophthalmol. 2019 Apr;103(4):488-493. doi: 10.1136/bjophthalmol-2018-312037. Epub 2018 Jun 6.
2
Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.玻璃体内化疗和激光治疗视网膜母细胞瘤新出现的视网膜下播散灶
Ophthalmic Genet. 2018 Jun;39(3):353-356. doi: 10.1080/13816810.2018.1443343. Epub 2018 Mar 7.
3
Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.
用于肿瘤微环境(TME)研究的视网膜母细胞瘤衍生肿瘤细胞和基质细胞的体外模型。
Cell Death Dis. 2024 Dec 18;15(12):905. doi: 10.1038/s41419-024-07285-2.
4
Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs.用反复给予拓扑替康或美法仑模拟视网膜母细胞瘤治疗会产生对经典药物的交叉耐药性,但对重新利用的药物不会产生交叉耐药性。
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):14. doi: 10.1167/iovs.65.14.14.
5
Protocol for quantifying N-Myc and global protein translation in neuroblastoma cells using click chemistry on polyvinylidene fluoride membranes.使用聚偏二氟乙烯膜上的点击化学法定量神经母细胞瘤细胞中N-Myc和整体蛋白质翻译的方案。
STAR Protoc. 2024 Dec 20;5(4):103377. doi: 10.1016/j.xpro.2024.103377. Epub 2024 Oct 11.
6
Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.癌症患者来源的基于细胞的模型:功能精准医学中的应用与挑战
Life (Basel). 2024 Sep 10;14(9):1142. doi: 10.3390/life14091142.
7
Organoids as a new approach for improving pediatric cancer research.类器官作为改善儿科癌症研究的新方法。
Front Oncol. 2024 May 21;14:1414311. doi: 10.3389/fonc.2024.1414311. eCollection 2024.
8
Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications.高级 3D 成像和类器官生物打印在生物医学研究和治疗应用中的应用。
Adv Drug Deliv Rev. 2024 May;208:115237. doi: 10.1016/j.addr.2024.115237. Epub 2024 Mar 5.
9
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.经典与创新证据在视网膜功能障碍治疗策略中的应用
Int J Mol Sci. 2024 Feb 9;25(4):2124. doi: 10.3390/ijms25042124.
10
Ceftriaxone exerts antitumor effects in MYCN-driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression.头孢曲松通过靶向 DDX3X 抑制翻译在 MYCN 驱动的视网膜母细胞瘤和神经母细胞瘤中发挥抗肿瘤作用。
Mol Oncol. 2024 Apr;18(4):918-938. doi: 10.1002/1878-0261.13553. Epub 2023 Nov 27.
人胰腺肿瘤类器官揭示了疾病进展过程中干细胞龛因子依赖性的丧失。
Cell Stem Cell. 2018 Mar 1;22(3):454-467.e6. doi: 10.1016/j.stem.2017.12.009. Epub 2018 Jan 11.
4
Molecular Anatomy of the Developing Human Retina.发育中的人类视网膜的分子解剖学
Dev Cell. 2017 Dec 18;43(6):763-779.e4. doi: 10.1016/j.devcel.2017.10.029. Epub 2017 Dec 7.
5
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.乳腺癌类器官活生物库捕获疾病异质性。
Cell. 2018 Jan 11;172(1-2):373-386.e10. doi: 10.1016/j.cell.2017.11.010. Epub 2017 Dec 7.
6
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.用于疾病建模和药物筛选的人原发性肝癌来源的类器官培养物。
Nat Med. 2017 Dec;23(12):1424-1435. doi: 10.1038/nm.4438. Epub 2017 Nov 13.
7
SKP2 Activation by Thyroid Hormone Receptor β2 Bypasses Rb-Dependent Proliferation in Rb-Deficient Cells.甲状腺激素受体β2激活SKP2可绕过Rb缺陷细胞中依赖Rb的增殖过程。
Cancer Res. 2017 Dec 15;77(24):6838-6850. doi: 10.1158/0008-5472.CAN-16-3299. Epub 2017 Sep 28.
8
Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.眼内注射拓扑替康治疗视网膜母细胞瘤难治性和复发性玻璃体内播散。
Br J Ophthalmol. 2018 Apr;102(4):490-495. doi: 10.1136/bjophthalmol-2017-310641. Epub 2017 Aug 26.
9
A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment.癌症干细胞模型作为肿瘤微环境中与癌症相关成纤维细胞的起源点。
Sci Rep. 2017 Jul 28;7(1):6838. doi: 10.1038/s41598-017-07144-5.
10
In Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 Mutations.使用纤毛病患者来源细胞的体外建模揭示了由CEP290突变引起的不同纤毛功能障碍。
Cell Rep. 2017 Jul 11;20(2):384-396. doi: 10.1016/j.celrep.2017.06.045.